3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow RX-10100: new trials by email Literature Review of RX-10100 trials Research Report on RX-10100
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder RX-10100 - Major Depressive Disorder | Phase 2 | Completed | Rexahn Pharmaceuticals, Inc. | 314 | 2010-12-01 | 2013-11-19 |
| Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD) RX-10100 - Major Depressive Disorder (MDD) | Phase 2 | Completed | Rexahn Pharmaceuticals, Inc. | 118 | 2009-01-01 | 2013-11-19 |
| Efficacy Study of RX-10100 to Treat Erectile Dysfunction (ED) Placebo, RX-10100 5mg, RX-10100 10mg - Erectile Dysfunction (ED) | Phase 2 | Completed | Rexahn Pharmaceuticals, Inc. | 40 | 2008-06-01 | 2009-05-05 |
Depressive Disorder, Major (2) · Depression (1) · Erectile Dysfunction (1)
Rexahn Pharmaceuticals, Inc. (3)
United States (3)
Christine Peterson, Ph.D (1) · Christine Peterson, PhD (1) · Hyungjoo Hugh Lee, MS (1)